Storia in 4 fonti

Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa

Viridian Therapeutics has scored an FDA

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

fiercepharma.comStai leggendo1 mese fa

Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa

Viridian Therapeutics has scored an FDA

originale

biopharmadive.com1 mese fa

Viridian may have edge over Amgen in eye drug showdown, analysts argue

The FDA, through a new approval, gave Viridian's drug a label that some on Wall Street believe makes it well-positioned to compete against Tepezza in the thyroid eye disease market.

Leggi questa versione → originale

Timeline cronologica

venerdì 26 giugno 2026·fiercepharma.com
Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals
In the past two weeks, CARsgen Therapeutics won the world's first regulatory approval for a solid tumor CAR-T, a behind-the-scenes look at Pfizer and Innovent Biologics' $10.5…
venerdì 26 giugno 2026·fiercepharma.com
Europe's CHMP reverses endorsement of Amgen's Tavneos as FDA hearing looms
As Amgen prepares to defend Tavneos’ market approval in the U.S., the company has received a bad omen overseas, with regulators recommending that the ANCA-associated vasculitis…

Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa

Confronto fonti

Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa

Viridian may have edge over Amgen in eye drug showdown, analysts argue

Timeline cronologica

Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals

Europe's CHMP reverses endorsement of Amgen's Tavneos as FDA hearing looms

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease - Virid

FDA approves Viridian eye drug, stoking competition with Amgen's Tepezza

FDA approves Viridian eye drug, stoking competition with Amgen's Tepezza

Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease - Virid

Viridian may have edge over Amgen in eye drug showdown, analysts argue

Unicycive turned away by FDA again over manufacturer’s plant shortfalls

FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program